The coumarin core is present as a characteristic structural motif in a large number of natural products and biologically active molecules.
1 Particularly, many of these naturally occurring 4-hydroxycoumarin and their synthetic analogues are important precursors for the synthesis of natural products and pharmaceuticals.
2 Enantioselective organocatalytic conjugate addition of 4-hydroxycoumarin to α,β-unsaturated ketones is a straightforward method to access warfarin which is an effective anticoagulants.
3 Although a number of reactions of α,β-unsaturated ketones as Michael acceptors have been reported, 3, 4 the corresponding β,γ-unsaturated α-keto esters have received relatively little attention as Michael acceptors. Recently, several groups have reported the asymmetric Michael addition of 4-hydroxycoumarin to β,γ-unsaturated α-keto esters catalyzed by Cu(II)-bisoxazoline, N,N'-dioxide-Ni(II) complexes, thiourea catalysts.
5 Although several efficient methods have been achieved by these systems, an effective method for the synthesis of warfarin analogues is still a challenge.
In the framework of our research program for the development of synthetic methods for the enantioselective construction of stereogenic carbon centers, 6 we recently reported asymmetric Michael addition reaction of active methylenes and methines using chiral catalysts.
7 Herein, we wish to describe the enantioselective asymmetric conjugate addition of 4-hydroxycoumarin to β,γ-unsaturated α-keto esters promoted by binaphthyl-modified thiourea organocatalyst.
We initially investigated a reaction system with 4-hydroxycoumarin (1) with (E)-ethyl 2-oxo-4-phenylbut-3-enoate (2a) in the presence of 10 mol % bifunctional organocatalysts ( Fig. 1 ) at room temperature. As shown in Table 1 , Takemoto's catalyst I and quinine-derived thiourea catalyst II effectively promoted the reaction with moderate enantioselectivities (entry 1-2). While both of binaphthyl-modified (thio)urea catalysts III-IV and squaramide organocatalysts V-VI bearing both central and axial chiralities gave high enantioselectivities (entries 3-6). The best result has been obtained with binaphthyl-modified thiourea catalyst III. We studied the effect of the ester group of (E)-4-phenylbut-3-en-2-one 2 using catalyst III in CH 2 Cl 2 (entries 3 and 7). When employing synthetically attractive, methyl ester of (E)-2-oxo-4-phenylbut-3-enoate (2b), the corresponding Michael adduct 3b was obtained with high enantioselectivity of 93% ee (entry 7). Among the solvents probed, the best results Enantiopurity was determined by HPLC analysis using a Chiralpak AD-H column. were achieved when the reaction was conducted in dibromomethane (entry 9). The present catalytic system tolerates catalyst loading down to 5 mol % without compromising both the yield and enantioselectivity (entries 9 and 13).
With the optimal reaction conditions in hand, we then carried on evaluating the generality of this protocol. The results of a representative selection of β,γ-unsaturated α-keto esters for the Michael addition are summarized in Table  2 . As demonstrated, organocatalyst III catalyzed the Michael addition of 4-hydroxycoumarin (1) to β,γ-unsaturated α-keto esters 2 proved to be a general approach for the synthesis of Michael adducts 3 with high to excellent enantiomeric excess (up to 99% ee). Absolute configuration of products 3 was determined comparison of the optical rotation and chiral HPLC data with the literature values.
5
In conclusion, we have developed organocatalytic enantioselective conjugate addition reaction of 4-hydroxycoumarin (1) to β,γ-unsaturated α-keto esters 2 to afford biologically valuable warfarin derivatives 3. The process is efficiently catalyzed by a binaphthyl-modified thiourea organocatalyst.
